Literature DB >> 21451962

Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models.

Xu Steven Xu1, Hui Wang, An Vermeulen.   

Abstract

Indirect response (IDR) models have been widely applied to pharmacodynamic (PD) modeling, particularly when delayed response (hysteresis) is present. This paper proposes a class of nonlinear discrete-time autoregressive (AR) models with drug concentrations acting as a time-varying covariate on the asymptote parameter or the autocorrelation parameter of the AR models as an alternative modeling approach for delayed response data. The mathematical derivations revealed the inherent connection between IDR models and nonlinear AR models, and showed that the nonlinear AR models approximate the IDR models when the time interval between response data is small. Simulations demonstrate that the IDR models and the corresponding AR models produce similar temporal response profiles, and as the time interval decreased (i.e., more intensive sampling designs), the AR model based parameter estimates were more comparable to those estimated from the IDR models. In conjunction with mixed-effects modeling, the nonlinear AR models have been shown to well describe a set of simulated longitudinal PK/PD data for a clinical study. Further extensions of the proposed nonlinear AR models are warranted to model irregular and sparse PK/PD data.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21451962     DOI: 10.1007/s10928-011-9197-1

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  25 in total

1.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

2.  An autoregressive linear mixed effects model for the analysis of longitudinal data which show profiles approaching asymptotes.

Authors:  Ikuko Funatogawa; Takashi Funatogawa; Yasuo Ohashi
Journal:  Stat Med       Date:  2007-04-30       Impact factor: 2.373

3.  Mathematical properties and parameter estimation for transit compartment pharmacodynamic models.

Authors:  James W T Yates
Journal:  Eur J Pharm Sci       Date:  2008-03-08       Impact factor: 4.384

4.  Approaches to handling pharmacodynamic baseline responses.

Authors:  Chantaratsamon Dansirikul; Hanna E Silber; Mats O Karlsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2008-04-30       Impact factor: 2.745

Review 5.  Characteristics of indirect pharmacodynamic models and applications to clinical drug responses.

Authors:  A Sharma; W J Jusko
Journal:  Br J Clin Pharmacol       Date:  1998-03       Impact factor: 4.335

6.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.

Authors:  K Swedberg; P Eneroth; J Kjekshus; L Wilhelmsen
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

7.  The use of an autoregressive model for the analysis of longitudinal data in epidemiologic studies.

Authors:  B Rosner; A Muñoz; I Tager; F Speizer; S Weiss
Journal:  Stat Med       Date:  1985 Oct-Dec       Impact factor: 2.373

8.  Autoregressive modelling for the analysis of longitudinal data with unequally spaced examinations.

Authors:  B Rosner; A Munoz
Journal:  Stat Med       Date:  1988 Jan-Feb       Impact factor: 2.373

9.  Mixed-effects state-space models for analysis of longitudinal dynamic systems.

Authors:  Dacheng Liu; Tao Lu; Xu-Feng Niu; Hulin Wu
Journal:  Biometrics       Date:  2010-09-03       Impact factor: 2.571

Review 10.  Pharmacokinetic/pharmacodynamic modelling in diabetes mellitus.

Authors:  Cornelia B Landersdorfer; William J Jusko
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.